Source: Virtual Congress 2020 – Tuberculosis and society
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Munteanu (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), D. Sion (Bucuresti, Romania), N. Cioran (Bucuresti, Romania). TB "cross-border" - a new challenge in tuberculosis management. 1447

Member's Comments

No comment yet.

Related content which might interest you: Childhood tuberculosis: progress requires an advocacy strategy now Source: Eur Respir J 2012; 40: 294-297 Year: 2012 Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 The global response to rifampicin-resistant tuberculosis: Current situation and recent trends Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Will clinicians keep their place in modern management of tuberculosis? Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement Source: Eur Respir J 2012; 40: 1081-1090 Year: 2012 Tuberculosis causes poverty but do tuberculosis control programmes reach the poor? Source: Annual Congress 2004 - Risks for tuberculosis Year: 2004 Closing the gap in surveillance of tuberculosis and HIV co-infection, and the need for clinician–public health alliances Source: Eur Respir J, 51 (3) 1702671; 10.1183/13993003.02671-2017 Year: 2018 TB disease and infection. Do we have real news? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017 Year: 2017 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal Source: Eur Respir J 2015; 45: 292-294 Year: 2015 A tale of two global emergencies: tuberculosis control efforts can learn from the Ebola outbreak Source: Eur Respir J 2015; 46: 293-296 Year: 2015 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015